NeueHealth (NEUE) Stock Price, News & Analysis

Company Overview

NeueHealth is a technology‐enabled healthcare services company that partners with health plans and providers to deliver value‐based care solutions. Its core offerings include a proprietary population health management platform, risk adjustment services, patient engagement tools and care coordination support. Through data analytics and integrated care teams, NeueHealth aims to optimize outcomes for members enrolled in Medicare Advantage and other government‐sponsored plans.

Founded in 2020 and headquartered in New York, NeueHealth leverages a mix of digital outreach and live care management to identify care gaps, support chronic condition management and drive quality performance. The company’s platform integrates claims data, clinical records and member-reported information to stratify risk and guide timely interventions. By aligning incentives with its payer and provider partners, NeueHealth seeks to reduce total cost of care while improving patient satisfaction and health outcomes.

Following its merger with a special purpose acquisition company and subsequent listing on the New York Stock Exchange under the ticker NEUE, NeueHealth has expanded its footprint across the United States. The company’s leadership team comprises veteran executives from both the healthcare and technology sectors, focusing on scaling operations, enhancing its software capabilities and forging new partnerships with health systems and insurers.

Key Stats

• Today's Range: $6.60 to $6.69
• 50-Day Range: $6.51 to $6.88
• 52-Week Range: $3.79 to $7.66
• Volume: 2,571 shs
• Average Volume: 15,606 shs
• Market Capitalization: $59.83 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $7.00
• Consensus Rating: Hold

NeueHealth Stock Analysis - MarketRank™

NeueHealth scored higher than 25% of companies evaluated by MarketBeat, and ranked 873rd out of 954 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.4 / 5
• Analyst Rating: Hold

Consensus Rating

NeueHealth has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.

Upside/Downside

The consensus price target for NeueHealth is close to its current price, suggesting limited near-term upside or downside.

Amount of Analyst Coverage

NeueHealth has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for NeueHealth are expected to grow in the coming year, from ($9.13) to ($9.01) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of NeueHealth is -0.42, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of NeueHealth is -0.42, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.43% of the float of NeueHealth has been sold short.

Short Interest Ratio / Days to Cover

NeueHealth has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in NeueHealth has recently increased by 43.82%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

NeueHealth does not currently pay a dividend.

Dividend Growth

NeueHealth does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.43% of the float of NeueHealth has been sold short.

Short Interest Ratio / Days to Cover

NeueHealth has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in NeueHealth has recently increased by 43.82%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 1.8 / 5
• News Sentiment: 0.32

News Sentiment

NeueHealth has a news sentiment score of 0.32. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.63 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for NeueHealth this week, compared to 1 article on an average week.

Company Ownership

• Score: 3.3 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, NeueHealth insiders have not sold or bought any company stock.

Percentage Held by Insiders

63.30% of the stock of NeueHealth is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

63.88% of the stock of NeueHealth is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

NEUE Stock Analysis - Frequently Asked Questions

How have NEUE shares performed this year?

NeueHealth's stock was trading at $7.42 at the beginning of 2025. Since then, NEUE stock has decreased by 10.6% and is now trading at $6.63.

How were NeueHealth's earnings last quarter?

NeueHealth, Inc. (NYSE:NEUE) announced its earnings results on Thursday, August, 7th. The company reported ($1.68) earnings per share for the quarter, topping analysts' consensus estimates of ($4.77) by $3.09. The firm earned $209.08 million during the quarter, compared to analyst estimates of $249.50 million.
Read the conference call transcript.

Who are NeueHealth's major shareholders?

NeueHealth's top institutional investors include Skandinaviska Enskilda Banken AB publ (0.32%). Insiders that own company stock include Jay Matushak, Tomas Orozco, Jeffery Michael Craig and Jeffrey J Scherman.
View institutional ownership trends.

How do I buy shares of NeueHealth?

Shares of NEUE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of NeueHealth own?

Based on aggregate information from My MarketBeat watchlists, some other companies that NeueHealth investors own include Jiuzi (JZXN), ARMOUR Residential REIT (ARR), Aethlon Medical (AEMD), Aditxt (ADTX), Ainos (AIMD), Adial Pharmaceuticals (ADIL) and Avalon GloboCare (ALBT).

Company Calendar

• Last Earnings: 8/07/2025
• Today: 9/18/2025
• Next Earnings (Estimated): 11/06/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Medical Services
• Sub-Industry: Insurance
• Current Symbol: NYSE:NEUE
• Previous Symbol: NYSE:NEUE
• CIK: 1671284
• Web: www.brighthealthgroup.com
• Phone: 612-238-1321
• Fax: N/A
• Employees: 1,252
• Year Founded: N/A

Price Target and Rating

• Average Price Target for NeueHealth: $7.00
• High Price Target: $7.00
• Low Price Target: $7.00
• Potential Upside/Downside: +2.8%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Trailing Twelve Months): ($15.97)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$134.68 million
• Net Margins: -9.08%
• Pretax Margin: -6.84%
• Return on Equity: N/A
• Return on Assets: -13.01%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.70
• Quick Ratio: 0.70

Sales & Book Value

• Annual Sales: $936.66 million
• Price / Sales: 0.07
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($163.57) per share
• Price / Book: -0.04

Miscellaneous

• Outstanding Shares: 9,020,000
• Free Float: 3,312,000
• Market Cap: $61.43 million
• Optionable: N/A
• Beta: 0.58